Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023		109,103,721
Beginning balance at Dec. 31, 2023	$ 489,648	$ 109	$ 1,142,578	$ (8,649)	$ (644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,093		32,093
Common stock issued under employee stock plans (in shares)		2,485,389
Common stock issued under employee stock plans	6,414	$ 3	6,411
Taxes related to net share settlement of equity awards	(34,860)		(34,860)
Unrealized income (loss) on derivative instruments, net of tax	1,797			1,797
Unrealized (loss) income on available for sale securities, net of tax	(2,253)			(2,253)
Net loss	(40,490)				(40,490)
Ending balance (in shares) at Mar. 31, 2024		111,589,110
Ending balance at Mar. 31, 2024	452,349	$ 112	1,146,222	(9,105)	(684,880)
Beginning balance (in shares) at Dec. 31, 2024		112,550,156
Beginning balance at Dec. 31, 2024	455,656	$ 113	1,193,022	2,676	(740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,255		32,255
Common stock issued under employee stock plans (in shares)		1,808,876
Common stock issued under employee stock plans	7,163	$ 2	7,161
Taxes related to net share settlement of equity awards	(26,447)		(26,447)
Repurchase of common stock (in shares)		(1,476,456)
Repurchase of common stock	(61,264)	$ (2)	(61,262)
Unrealized income (loss) on derivative instruments, net of tax	(6,231)			(6,231)
Unrealized (loss) income on available for sale securities, net of tax	2,393			2,393
Common stock issued for debt conversion (in shares)		32
Common stock issued for debt conversion	1		1
Net loss	(35,783)				(35,783)
Ending balance (in shares) at Mar. 31, 2025		112,882,608
Ending balance at Mar. 31, 2025	$ 367,743	$ 113	$ 1,144,730	$ (1,162)	$ (775,938)